Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650246 · ClinicalTrials.gov registry record · Phase 3
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Phase 3 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 143
- Enrollment target
NCT01650246 is a Phase 3 study that has completed, run by Ardea Biosciences. The registered enrollment target is 143 participants.
The verdict
NCT01650246, a Phase 3 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 143 participants
- Enrollment target
Study Summary
This study will assess the serum uric acid lowering effects and safety of lesinurad over a long-term timeframe.
Interventions
- DRUG lesinurad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01650246
The ClinicalTrials.gov registry entry for NCT01650246 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lesinurad is the first listed.
NCT01650246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01650246 about?
NCT01650246 is a clinical study titled "Open-Label Lesinurad Monotherapy Extension Study in Gout". This study will assess the serum uric acid lowering effects and safety of lesinurad over a long-term timeframe.
What is the current status of trial NCT01650246?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 143 participants. The study started on 2012-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01650246?
The interventions under investigation include: lesinurad (DRUG).
Who is sponsoring clinical trial NCT01650246?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.